Liposomal subunit vaccine against Epstein-Barr virus-induced malignant lymphoma - PubMed
. 1986 Mar;320(6057):87-8.
doi: 10.1038/320087b0.
- PMID: 3005876
- DOI: 10.1038/320087b0
Liposomal subunit vaccine against Epstein-Barr virus-induced malignant lymphoma
G Gregoriadis. Nature. 1986 Mar.
No abstract available
Similar articles
-
Epstein-Barr virus. Dream or reality of a vaccine?
Beale AJ. Beale AJ. Nature. 1985 Nov 21-27;318(6043):230. doi: 10.1038/318230a0. Nature. 1985. PMID: 2999603 No abstract available.
-
Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.
Epstein MA, Morgan AJ. Epstein MA, et al. Clin Exp Immunol. 1983 Aug;53(2):257-71. Clin Exp Immunol. 1983. PMID: 6309441 Free PMC article. Review. No abstract available.
-
Epstein MA, Randle BJ, Finerty S, Kirkwood JK. Epstein MA, et al. Clin Exp Immunol. 1986 Mar;63(3):485-90. Clin Exp Immunol. 1986. PMID: 3011324 Free PMC article.
-
The Epstein-Barr virus genome and phenotypic expression during lytic cycle.
Pearson GR. Pearson GR. AIDS Res. 1986 Dec;2 Suppl 1:S49-56. AIDS Res. 1986. PMID: 3030347
-
A prototype vaccine to prevent Epstein-Barr virus-associated cancers.
Epstein M. Epstein M. Chemioterapia. 1987 Jun;6(2 Suppl):655-8. Chemioterapia. 1987. PMID: 2855615 Review. No abstract available.
Cited by
-
Engineering nanomedicines for improved melanoma therapy: progress and promises.
Bei D, Meng J, Youan BB. Bei D, et al. Nanomedicine (Lond). 2010 Nov;5(9):1385-99. doi: 10.2217/nnm.10.117. Nanomedicine (Lond). 2010. PMID: 21128721 Free PMC article. Review.
-
Immunomodulation by liposome entrapped allergen.
Arora N, Gangal SV. Arora N, et al. Mol Cell Biochem. 1990 Sep 21;97(2):173-9. doi: 10.1007/BF00221059. Mol Cell Biochem. 1990. PMID: 2280764
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical